login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GreenLight Biosciences Holdings PBC (GRNA) Stock News
USA
- NASDAQ:GRNA -
US39536G1058
-
Common Stock
0.2995
USD
0 (-0.03%)
Last: 7/21/2023, 8:00:02 PM
0.2995
USD
0 (0%)
After Hours:
7/21/2023, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GRNA Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: GreenLight Biosciences
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
2 years ago - By: GreenLight Biosciences
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
2 years ago - By: GreenLight Biosciences
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
2 years ago - By: Benzinga
- Mentions:
TTOO
TCRX
MNPR
NMTR
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
2 years ago - By: Benzinga
Recap: GreenLight Biosciences Q1 Earnings
2 years ago - By: GreenLight Biosciences
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
2 years ago - By: Kaskela Law LLC
- Mentions:
ENVI
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of GreenLight Biosciences Holdings and Encourages Long-Term GRNA / ENVI Shareholders to Contact the Firm
2 years ago - By: Levi & Korsinsky, LLP
GRNA ALERT: Levi & Korsinsky, LLP Announces an Investigation of Greenlight Biosciences
2 years ago - By: Kahn Swick & Foti, LLC
GREENLIGHT BIOSCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GreenLight Biosciences Holdings, PBC - GRNA
2 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether GreenLight Biosciences Holdings, PBC has obtained a Fair Price in its transaction with Fall Line
2 years ago - By: Halper Sadeh LLC
GRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GreenLight Biosciences Holdings, PBC Is Fair to Shareholders
2 years ago - By: Seeking Alpha
GreenLight Biosciences 36% higher merger Fall Line Endurance Fund (NASDAQ:GRNA)
2 years ago - By: GreenLight Biosciences
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
2 years ago - By: GreenLight Biosciences
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
2 years ago - By: GreenLight Biosciences
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
3 years ago - By: GreenLight Biosciences
GreenLight Biosciences Releases Inaugural Sustainability Report
3 years ago - By: GreenLight Biosciences
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
3 years ago - By: GreenLight Biosciences
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
3 years ago - By: GreenLight Biosciences
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
3 years ago - By: GreenLight Biosciences
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
3 years ago - By: GreenLight Biosciences
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
Please enable JavaScript to continue using this application.